Detection of nosocomial toxigenic Clostridium difficile associated diarrhea in children by conventional PCR
Author(s) -
Hala S. Arif,
Jabbar Salman Hassan,
Thana R Abdul Rhman,
Wurood J Hassan
Publication year - 2018
Publication title -
diyala journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 2617-8982
pISSN - 2219-9764
DOI - 10.26505/djm.14023701002
Subject(s) - clostridium difficile , diarrhea , microbiology and biotechnology , medicine , biology , antibiotics
Background: Clostridium difficile is a gram positive anaerobic spore forming bacteria. C. difficile–associated disease is a critical clinical issue that is accepted to happen mainly after hospitalization and used of expansive range anti-infection agents. Objective:To define the rate of C. difficile infections isolated from children patients suffering from diarrhea, detection profile toxigenicity of C. difficile strains for toxin A and toxin B by using of PCR, and revise different risk factors of C. difficile infections. Patients and Methods: This cross-sectional study included 50 patients who hospitalized for at least 2 days before the appearance of three or more unformed or liquid stools for 24h, genomic DNA was extracted by using 10% fecal supernatant and a ready kit was used for extraction according to manufacturer instructions. Molecular detection of toxigenic C. difficile done by using the specific primer sequences in polymerase chain reaction. Results: Current study showed diarrhea was the most prominent complain among the study population accounting for 41(82%), of whom 39(78%) presented with watery diarrhea. 38(76%) patients had no fever. The most comorbid disease was inflammatory bowel disease (IBD) with 7 (14%) patients. Forty-six (92%) cases had no history of hospitalization in the last 3 months versus only 8% had such history. PCR revealed that 16 (32%) samples were positive for tcdB gene, while all samples were negative for genes tcdA. Conclusion: The study showed a relationship between previously diagnosed patients with IBD and exacerbations with C. difficile infections (CDIs). Clinically the toxin B alone elicits severe enterotoxic effects which increase rate of (CDIs).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom